(Q33827961)

29 July 2017

1 reference

title

Antibiotic cycling and marketing into the 21st century: a perspective from the pharmaceutical industry (English)

1 reference

29 July 2017

0 references

B S Lavin

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Infection Control and Hospital Epidemiology

29 July 2017

published in

1 reference

29 July 2017

volume

21

1 reference

29 July 2017

issue

1 Suppl

1 reference

29 July 2017

page(s)

S32-5

1 reference

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

29 July 2017

cites work

1 reference

The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals

21 January 2018

1 reference

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

21 January 2018

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

How the pharmaceutical industry brings an antibiotic drug to market in the United States

21 January 2018

1 reference

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory

21 January 2018

1 reference

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

21 January 2018

1 reference

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/503171

1 reference

29 July 2017

1 reference